This underlies our initial observations that the aberrant activation of the PI3K/mTOR signaling pathway is a widespread event in HNSCC (>80% of all HPV– and HPV+ cases; refs. 12, 13). This evidence concerns the gene PIK3CA and head and neck squamous cell carcinoma.